You are here

Singapore to get first dibs on any successful Arcturus Covid-19 vaccine

US firm, Duke-NUS aim to produce effective single-dose vaccine as nations race to secure supply


SINGAPORE sought out US Covid-19 vaccine developer Arcturus Therapeutics Holdings and is funding its research in order to secure the first doses of any successful final product, in a reflection of the growing urgency in the race for immunisation.

San Diego-based Arcturus...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to